Abbott Laboratories Philippines Inc (Philippines)

Abbott Laboratories Philippines Inc is the Philippine affiliate of Abbott, a global healthcare company, and is engaged in the marketing, distribution, and, for selected product lines, local manufacturing support of a broad range of health-care products. Its operations in the Philippines span four main segments: Nutrition, Established Pharmaceuticals, Diagnostics, and Diabetes Care, with additional activities in cardiovascular and medical devices. In Nutrition, the company offers science-based nutritional products for infants, children, adults, and the elderly, including brands such as Similac, PediaSure, Ensure, and Glucerna, distributed through hospitals, pharmacies, groceries, and modern trade channels. In Established Pharmaceuticals, Abbott Laboratories Philippines markets branded generic medicines for key therapeutic areas including gastroenterology, women's health, cardiometabolic conditions, pain management, and respiratory care, serving both physicians and retail pharmacies. The Diagnostics segment provides laboratory systems and assays for clinical chemistry, immunoassay, and rapid testing used by hospitals and diagnostic centers, while Diabetes Care supplies blood glucose monitoring systems and continuous glucose monitoring solutions such as FreeStyle devices, supporting self-management for people with diabetes. From its base in Metro Manila, the company manages a nationwide sales, medical, and distribution network that serves both public and private healthcare providers. Strategically, Abbott Laboratories Philippines Inc focuses on strengthening its position as a partner to the healthcare community by combining international research and product innovation with local medical education, patient-support programs, and access initiatives. It aims to drive growth by expanding penetration of its nutrition and diabetes portfolios, introducing new diagnostics and device technologies, and aligning its operations with Abbott's global standards in quality, compliance, and corporate responsibility.